Cardiac Toxicity and Oncology

Cardiac Toxicity and Oncology refers to the adverse effects that cancer treatments, particularly chemotherapy and radiation, can have on the heart and cardiovascular system. While cancer therapies are crucial for treating cancer, some of these treatments can cause damage to the heart, leading to cardiotoxicity. This toxicity can manifest as a variety of heart-related complications, ranging from mild effects like high blood pressure to more severe outcomes such as heart failure.

    Related Conference of Cardiac Toxicity and Oncology

    August 17-18, 2026

    4th International Conference on World Heart Care

    Toronto, Canada
    August 27-28, 2026

    40th European Cardiology Conference

    Berlin, Germany
    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    Cardiac Toxicity and Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in